Investment
Features
FeesSafety
Academy
More
Pluang+

Compare TAL Education Group American Depositary Shares (TAL) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

TAL Education Group American Depositary SharesTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

TAL Education Group American Depositary Shares vs Vir Biotechnology Inc. Common Stock — how do they compare? TAL Education Group American Depositary Shares trades at $12.44 (market cap $7.01B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: TAL Education Group American Depositary Shares is far larger — about 3.9× Vir Biotechnology Inc. Common Stock's market cap, and TAL Education Group American Depositary Shares is trading nearer its 52-week high, Vir Biotechnology Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold TAL Education Group American Depositary Shares for 3 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

TALVIR
Market Cap
$7.01B$1.80B
Volume
3,223,6781,782,836
Sector
Consumer StaplesHealth
52-Week High
$12.91$11.78
52-Week Low
$8.95$5.12
Typical Hold Time
3 Days0 Days
Enterprise Value
$4.54B$1.36B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

TAL Education Group American Depositary Shares

TAL Education Group trades at $12.64, down 0.63% with strong bullish technical signals from moving averages. The company demonstrates impressive fundamental strength with 28.43% net income margin and 23.72% ROE, supported by three consecutive earnings beats. Revenue growth accelerated from $2.25B in 2025 to $3.2B in 2026, while profitability surged from $85M to $907M net income. Analyst consensus shows 42.86% buy ratings with price targets suggesting 27.63% upside potential.

TAL presents a compelling investment case with strong earnings momentum and attractive valuation at 7.92 P/E. However, investors face risks from China's regulatory environment and the company's negative cash flow position of -$465.75M in 2025. The technical setup supports near-term upside with key resistance at $13 and support at $12, while institutional sentiment remains positive despite cash flow concerns.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TAL
100% Buy0% Sell
Avg holding period · 3 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

About TAL Education Group American Depositary Shares

TAL Education Group provides smart learning solutions in China. Its offerings combine teaching content, technology, and learning services through various online and offline formats.

Read more on TAL →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →